Christine Briggs
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Christine Briggs has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Afshin Beheshti
McGowan Institute for Regenerative Medicine, Department of Surgery, University of Pittsburgh; Center for Space Biomedicine, Trivedi Institute for Space and Global Biomedicine; Computational and Systems Biology, University of Pittsburgh; Department of Bioengineering, University of Pittsburgh; Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, USA
1 shared publication - Edward A. Rietman
Manning College of Information & Computer Sciences University of Massachusetts Amherst
1 shared publication - Kathleen P. Wilkie
Department of Mathematics, Toronto Metropolitan University, Toronto, ON, Canada
1 shared publication - Lili Ma
Center of Cancer Systems Biology; GeneSys Research Institute; Tufts University School of Medicine; Boston, MA USA
1 shared publication - Lynn Hlatky
Center of Cancer Systems Biology, Tufts University School of Medicine, Boston, MA, USA
1 shared publication - Nava Almog
Center of Cancer Systems Biology; Tufts University School of Medicine; Boston, MA
1 shared publication
Latest Publications
- Open Access
- 1 July 2013
- Published by Taylor & Francis in Transcription
- Vol. 4 (4) , 177-191
Transcriptional changes induced by the tumor dormancy-associated microRNA-190
Tumor dormancy is a highly prevalent stage in cancer progression. We have previously generated and characterized in vivo experimental models of human tumor dormancy in which micro-tumors remain occult until they spontaneously shift into rapid tumor growth. We showed that the dormant micro-tumors undergo a stable microRNA (miRNA) switch during their transition from dormancy to a fast-growing phenotype and reported the identification of a consensus signature of human tumor dormancy-associated miRNAs (DmiRs). miRNA-190 (miR-190) is among the most upregulated DmiRs in all dormant tumors analyzed. Upregulation of miR-190 led to prolonged tumor dormancy in otherwise fast-growing glioblastomas and osteosarcomas. Here we investigate the transcriptional changes induced by miR-190 expression in cancer cells and show similar patterns of miR-190 mediated transcriptional reprogramming in both glioblastoma and osteosarcoma cells. The data suggests that miR-190 mediated effects rely on an extensive network of molecular changes in tumor cells and that miR-190 affects several transcriptional factors, tumor suppressor genes and interferon response pathways. The molecular mechanisms governing tumor dormancy described in this work may provide promising targets for early prevention of cancer and may lead to novel treatments to convert the malignant tumor phenotype into an asymptomatic dormant state.
- 1 July 2013
- Published by Taylor & Francis in Transcription
- Vol. 4 (4) , 177-191
Open AccessTranscriptional changes induced by the tumor dormancy-associated microRNA-190
Tumor dormancy is a highly prevalent stage in cancer progression. We have previously generated and characterized in vivo experimental models of human tumor dormancy in which micro-tumors remain occult until they spontaneously shift into rapid tumor growth. We showed that the dormant micro-tumors undergo a stable microRNA (miRNA) switch during their transition from dormancy to a fast-growing phenotype and reported the identification of a consensus signature of human tumor dormancy-associated miRNAs (DmiRs). miRNA-190 (miR-190) is among the most upregulated DmiRs in all dormant tumors analyzed. Upregulation of miR-190 led to prolonged tumor dormancy in otherwise fast-growing glioblastomas and osteosarcomas. Here we investigate the transcriptional changes induced by miR-190 expression in cancer cells and show similar patterns of miR-190 mediated transcriptional reprogramming in both glioblastoma and osteosarcoma cells. The data suggests that miR-190 mediated effects rely on an extensive network of molecular changes in tumor cells and that miR-190 affects several transcriptional factors, tumor suppressor genes and interferon response pathways. The molecular mechanisms governing tumor dormancy described in this work may provide promising targets for early prevention of cancer and may lead to novel treatments to convert the malignant tumor phenotype into an asymptomatic dormant state.